Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
This list of potential positions covers Entities with exposure to distribution of Marijuana. Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States in USA. Please note, we provide buy hold or sell recommendation only in the context of selected investment horizon assuming investor has average attitude towards taking risk. Please also consider using Portfolio Positions Ratings and Equity Ratings tools to further calibrate your research.
Story appears to be empty
Aerogrow International (AERO)
The company has return on total asset (ROA) of 17.44 % which means that it generated a profit of $17.44 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 59.71 %, meaning that it created $59.71 on every $100 dollars invested by stockholders. Aerogrow International's management efficiency ratios could be used to measure how well Aerogrow International manages its routine affairs as well as how well it operates its assets and liabilities. The firm currently falls under 'Small-Cap' category with a current market capitalization of 110.19 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aerogrow International's market, we take the total number of its shares issued and multiply it by Aerogrow International's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Cara Therapeutic (CARA)
The company has return on total asset (ROA) of (0.493) % which means that it has lost $0.493 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.098) %, meaning that it created substantial loss on money invested by shareholders. Cara Therapeutic's management efficiency ratios could be used to measure how well Cara Therapeutic manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.89. The current year's Return On Capital Employed is expected to grow to -1.15. At present, Cara Therapeutic's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.31, whereas Non Current Assets Total are forecasted to decline to about 9.2 M. This firm currently falls under 'Micro-Cap' category with a current market capitalization of 38.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cara Therapeutic's market, we take the total number of its shares issued and multiply it by Cara Therapeutic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Short Long Term Debt Total
45.33 Million
At present, Cara Therapeutic's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting.
CV Sciences (CVSI)
The company has return on total asset (ROA) of (0.5182) % which means that it has lost $0.5182 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.36) %, meaning that it created substantial loss on money invested by shareholders. CV Sciences' management efficiency ratios could be used to measure how well CV Sciences manages its routine affairs as well as how well it operates its assets and liabilities. The firm currently falls under 'Nano-Cap' category with a current market capitalization of 7.85 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CV Sciences's market, we take the total number of its shares issued and multiply it by CV Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CV Sciences seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of CV Sciences from evaluating the firm fundamentals such as Shares Outstanding of 150.1 M, shares owned by insiders of 2.01 %, and Return On Asset of -0.52 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued equities and trading away overvalued equities since, sooner or later, asset prices and their ongoing real values will grow together.
Hemp Inc (HEMP)
The company has return on total asset (ROA) of (0.0558) % which means that it has lost $0.0558 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7378) %, meaning that it created substantial loss on money invested by shareholders. Hemp's management efficiency ratios could be used to measure how well Hemp manages its routine affairs as well as how well it operates its assets and liabilities. The entity currently falls under 'Nano-Cap' category with a current market capitalization of 7.06 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hemp's market, we take the total number of its shares issued and multiply it by Hemp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Lexaria Bioscience Corp (LXRP)
The company has return on total asset (ROA) of (87.72) % which means that it has lost $87.72 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (164.27) %, meaning that it created substantial loss on money invested by shareholders. Lexaria Bioscience's management efficiency ratios could be used to measure how well Lexaria Bioscience manages its routine affairs as well as how well it operates its assets and liabilities. The entity currently falls under 'Micro-Cap' category with a current market capitalization of 18.58 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lexaria Bioscience's market, we take the total number of its shares issued and multiply it by Lexaria Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Mentor Capital (MNTR)
The company has return on total asset (ROA) of 0.0333 % which means that it generated a profit of $0.0333 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1981 %, meaning that it created $0.1981 on every $100 dollars invested by stockholders. Mentor Capital's management efficiency ratios could be used to measure how well Mentor Capital manages its routine affairs as well as how well it operates its assets and liabilities. The entity currently falls under 'Nano-Cap' category with a current market capitalization of 975.01 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mentor Capital's market, we take the total number of its shares issued and multiply it by Mentor Capital's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
The Supreme Cannabis (SPRWF)
The company has return on total asset (ROA) of (9.9) % which means that it has lost $9.9 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (7.85) %, meaning that it generated substantial loss on money invested by shareholders. Supreme Cannabis' management efficiency ratios could be used to measure how well Supreme Cannabis manages its routine affairs as well as how well it operates its assets and liabilities. This firm currently falls under 'Small-Cap' category with a current market capitalization of 204.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Supreme Cannabis's market, we take the total number of its shares issued and multiply it by Supreme Cannabis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Surna Inc (SRNA)
The company has return on total asset (ROA) of (20.13) % which means that it has lost $20.13 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (196.34) %, meaning that it created substantial loss on money invested by shareholders. Surna's management efficiency ratios could be used to measure how well Surna manages its routine affairs as well as how well it operates its assets and liabilities. The entity currently falls under 'Micro-Cap' category with a current market capitalization of 12.42 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Surna's market, we take the total number of its shares issued and multiply it by Surna's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Macroaxis financial leverage refers to using borrowed capital as a funding source to finance Macroaxis ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Macroaxis financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Macroaxis' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Macroaxis' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Macroaxis's total debt and its cash.
Story appears to be empty
Aerogrow International (AERO)
The company has return on total asset (ROA) of 17.44 % which means that it generated a profit of $17.44 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 59.71 %, meaning that it created $59.71 on every $100 dollars invested by stockholders. Aerogrow International's management efficiency ratios could be used to measure how well Aerogrow International manages its routine affairs as well as how well it operates its assets and liabilities. The firm currently falls under 'Small-Cap' category with a current market capitalization of 110.19 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aerogrow International's market, we take the total number of its shares issued and multiply it by Aerogrow International's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Cara Therapeutic (CARA)
The company has return on total asset (ROA) of (0.493) % which means that it has lost $0.493 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.098) %, meaning that it created substantial loss on money invested by shareholders. Cara Therapeutic's management efficiency ratios could be used to measure how well Cara Therapeutic manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.89. The current year's Return On Capital Employed is expected to grow to -1.15. At present, Cara Therapeutic's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.31, whereas Non Current Assets Total are forecasted to decline to about 9.2 M. This firm currently falls under 'Micro-Cap' category with a current market capitalization of 38.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cara Therapeutic's market, we take the total number of its shares issued and multiply it by Cara Therapeutic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Short Long Term Debt Total
45.33 Million
At present, Cara Therapeutic's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting.
CV Sciences (CVSI)
The company has return on total asset (ROA) of (0.5182) % which means that it has lost $0.5182 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.36) %, meaning that it created substantial loss on money invested by shareholders. CV Sciences' management efficiency ratios could be used to measure how well CV Sciences manages its routine affairs as well as how well it operates its assets and liabilities. The firm currently falls under 'Nano-Cap' category with a current market capitalization of 7.85 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CV Sciences's market, we take the total number of its shares issued and multiply it by CV Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CV Sciences seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of CV Sciences from evaluating the firm fundamentals such as Shares Outstanding of 150.1 M, shares owned by insiders of 2.01 %, and Return On Asset of -0.52 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued equities and trading away overvalued equities since, sooner or later, asset prices and their ongoing real values will grow together.
Hemp Inc (HEMP)
The company has return on total asset (ROA) of (0.0558) % which means that it has lost $0.0558 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7378) %, meaning that it created substantial loss on money invested by shareholders. Hemp's management efficiency ratios could be used to measure how well Hemp manages its routine affairs as well as how well it operates its assets and liabilities. The entity currently falls under 'Nano-Cap' category with a current market capitalization of 7.06 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hemp's market, we take the total number of its shares issued and multiply it by Hemp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Lexaria Bioscience Corp (LXRP)
The company has return on total asset (ROA) of (87.72) % which means that it has lost $87.72 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (164.27) %, meaning that it created substantial loss on money invested by shareholders. Lexaria Bioscience's management efficiency ratios could be used to measure how well Lexaria Bioscience manages its routine affairs as well as how well it operates its assets and liabilities. The entity currently falls under 'Micro-Cap' category with a current market capitalization of 18.58 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lexaria Bioscience's market, we take the total number of its shares issued and multiply it by Lexaria Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Mentor Capital (MNTR)
The company has return on total asset (ROA) of 0.0333 % which means that it generated a profit of $0.0333 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1981 %, meaning that it created $0.1981 on every $100 dollars invested by stockholders. Mentor Capital's management efficiency ratios could be used to measure how well Mentor Capital manages its routine affairs as well as how well it operates its assets and liabilities. The entity currently falls under 'Nano-Cap' category with a current market capitalization of 975.01 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mentor Capital's market, we take the total number of its shares issued and multiply it by Mentor Capital's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
The Supreme Cannabis (SPRWF)
The company has return on total asset (ROA) of (9.9) % which means that it has lost $9.9 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (7.85) %, meaning that it generated substantial loss on money invested by shareholders. Supreme Cannabis' management efficiency ratios could be used to measure how well Supreme Cannabis manages its routine affairs as well as how well it operates its assets and liabilities. This firm currently falls under 'Small-Cap' category with a current market capitalization of 204.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Supreme Cannabis's market, we take the total number of its shares issued and multiply it by Supreme Cannabis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Surna Inc (SRNA)
The company has return on total asset (ROA) of (20.13) % which means that it has lost $20.13 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (196.34) %, meaning that it created substantial loss on money invested by shareholders. Surna's management efficiency ratios could be used to measure how well Surna manages its routine affairs as well as how well it operates its assets and liabilities. The entity currently falls under 'Micro-Cap' category with a current market capitalization of 12.42 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Surna's market, we take the total number of its shares issued and multiply it by Surna's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Rifka Kats is a Member of Macroaxis Editorial Board. Rifka writes about retail product and service companies from the perspective of a regular consumer and sophisticated investor at the same time. She is passionate about corporate ethics and equality in the workforce. View Profile
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Please refer to our Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com
Did you try this?
Run Portfolio Comparator Now
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any private could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
